COMMUNIQUÉS West-GlobeNewswire

CMS Grants New Technology Add-on Payment to ZEMDRI™ (plazomicin)
03/08/2018
--- Add-on Payment to Provide Additional Medicare Reimbursement up to 50% of the cost of ZEMDRI Prescribed to Medicare patients in Hospital Inpatient Setting --- SOUTH SAN FRANCISCO, Calif., Aug. 03, 2018 (GLOBE [...]
Spark Therapeutics Recognized for Second-straight Year as One of Philadelphia’s “Best Places to Work” by the Philadelphia Business Journal
03/08/2018
PHILADELPHIA, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that it has been [...]
Innovate Biopharmaceuticals to Host Clinical and Scientific Update Event on Thursday, September 6, 2018, in New York City
03/08/2018
RALEIGH, N.C., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases [...]
Oncolytics Biotech® Reports 2018 Second Quarter Results
03/08/2018
CALGARY, Alberta and SAN DIEGO, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (TSX: ONC), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
Aclaris Therapeutics Reports Second Quarter 2018 Financial Results and Provides Update on Clinical and Commercial Developments
03/08/2018
Management to Host Conference Call at 8:00 AM ET today WAYNE, Pa., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, [...]
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2018
03/08/2018
RANCHO CUCAMONGA, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2018 ended June 30, 2018, after the [...]
HMS Holdings Corp. Reports Second Quarter 2018 Results
03/08/2018
Total Q2 Revenue of $146.8 Million / YTD Total Revenue Up 13% Excluding Q1 Reserve Release Record Quarterly Commercial Revenue of $80.5 Million in Q2 – Up 16% Compared to Q2’17 Full-Year 2018 Outlook Raised - Including [...]
Athersys Makes Important Leadership Hire to Carry Out Its Manufacturing Strategy
03/08/2018
Company Appoints Greg Liposky, MBA as Senior Vice President of Commercial Manufacturing CLEVELAND, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced the addition of an experienced manufacturing [...]
William Demant: Investor news - William Demant and Philips partner in hearing healthcare
03/08/2018
Investor news 3 August 2018 William Demant and Philips partner in hearing healthcare Based on a shared vision of improving the lives of people through innovative healthcare, William Demant will bring Philips-branded [...]
Shire plc : Rule 2.9 Announcement
03/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 3 August 2018 [...]
Fagron realised organic turnover growth of 8.5%
03/08/2018
Regulated information | Consolidated results for the first semester of 2018 Nazareth (Belgium)/Rotterdam (the Netherlands), 3 August 2018 Fagron realised organic turnover growth of 8.5% Organic turnover growth in all [...]
HitGen Launching Initiative to Discover New Medicines to Combat Tuberculosis and Malaria
03/08/2018
Grant Funding provided by the Bill & Melinda Gates Foundation to Use HitGen’s DNA-Encoded Library Technology CHENGDU, China, Aug. 03, 2018 (GLOBE NEWSWIRE) -- HitGen Ltd., a privately held biotech company, announced [...]
Idera Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
02/08/2018
Abstract accepted for 2018 European Society of Medical Oncology Annual Meeting Cash runway into first quarter of 2020 EXTON, Pa., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a [...]
Profound Medical to Release Second Quarter 2018 Financial Results on August 14 – Conference Call to Follow
02/08/2018
TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months of 2018
02/08/2018
Q2 2018 total revenues of $220 million, net income of $50 million Reaffirms full year 2018 financial forecast and operational goals GAITHERSBURG, Md., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: [...]
The Ensign Group Reports Second Quarter Results
02/08/2018
Conference Call and Webcast scheduled for tomorrow, August 3, 2018 at 10:00 am PT MISSION VIEJO, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq:ENSG), the parent company of the Ensign™ group of [...]
Alpha Pro Tech, Ltd. Announces Financial Results for the Second Quarter Ended June 30, 2018
02/08/2018
Revenue for the second quarter of 2018 increased 7.3% to $12.1 million, compared to $11.3 million for the second quarter of 2017 Net income for the second quarter of 2018 was $959,000, or $0.07 per diluted share, [...]
Corvus Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
02/08/2018
BURLINGAME, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Tetraphase Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Highlights
02/08/2018
WATERTOWN, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]

Pages